Response Biomedical said this week that Jonathan Wang has been appointed to the company's board of directors.

Wang was previously a director at Response Biomedical in 2010 and 2011 and serves on the board at ForteBio. He is also senior managing director at Orbimed and a co-founder of that company's Asia-focused venture capital fund. He previously was a GM at Burrill Greater China Group and he worked for other venture capital funds focused on Asia.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.